CPI News Alert IQ Real Return ETF (CPI) 26.65 02/14/2015 06:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
IQ Real Return ETF (CPI) 26.65 $CPI

Why Friday Will Be Tough Trading
Markos Kaminis - at Seeking Alpha - Fri Jan 16, 8:28AM CST

CPI: 26.65 (unch), SPY: 209.78 (+0.86), GS: 189.00 (-0.78), QQQ: 106.91 (+0.91), BOND: 109.14 (-0.10), VXX: 30.97 (-0.38), GLD: 117.98 (+0.64), OIL: 12.01 (+0.34), DIA: 180.34 (+0.50), BAC: 16.61 (-0.06), INTC: 34.36 (+0.23), UUP: 24.91 (-0.01)

Call Off The Deflation Warning
The Inflation Trader - Seeking Alpha - Wed Jan 07, 3:55PM CST
Today's column is a brief one, as I need to post a correction. Not a correction to my stuff, mind you, but to others. Pictures like the below have been circulating now for a couple of weeks. This is a chart of the two-year inflation...
CPI: 26.65 (unch), SPY: 209.78 (+0.86), SCHP: 54.49 (-0.11)

Summary Of My Post-CPI Comments
The Inflation Trader - Seeking Alpha - Thu Nov 20, 12:56PM CST
Below is a summary of my post-CPI tweets. You can follow me @inflation_guy. CPI +0.0%, +0.2% on core. Above expectations. Core 0.203% before the rounding to 1 decimal place. So this didn't "round up" to 0.2%. Y/y core at 1.82%, versus...
CPI: 26.65 (unch), SPY: 209.78 (+0.86)

The Birth, Growth, Maturity and Death of the Current Bull Market
at The Street - Tue Jun 17, 4:30PM CDT
This bull market is getting very close to the end. It cannot continue.
CPI: 26.65 (unch), SPY: 209.78 (+0.86), BRCM: 45.69 (+0.23), DB: 32.29 (+0.70), FCS: 16.37 (-0.07), SMH: 56.39 (+0.33), XLU: 45.17 (-0.70), VNQ: 85.06 (-0.57), XLE: 82.04 (+1.70)

Appointment, New Survey, Financial Results, Interim management Statements, and Prestigious Awards - Analyst Notes on Bwin.party, Capita, Electra, IP Group and National Grid
PR Newswire Europe - Fri Jun 13, 12:01AM CDT
LONDON, June 13, 2014 /PRNewswire/ --
IPO: 24.00 (+0.09), CPI: 26.65 (unch), NG: 3.96 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading